Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients with type 2 diabetes mellitus -a randomized comparative study of vonoprazan vs esomeprazole - - Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients with type 2 diabetes mellitus -a randomized comparative study of vonoprazan vs esomeprazole

Hachinohe City Hospital Department of Endocrinology and Diabetes0 个研究点目标入组 40 人开始时间: 2017年3月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)The patients with warning signs such as vomiting, gastrointestinal bleeding and sudden weight loss 2)The patients with confirmed or suspected malignant disease 3)The patients with a history of gastrointestinal resection or vagotomy 4)The patients with a history of irritable bowel syndrome 5)The patients whose participation in this study would be contraindicated due to complications such as serious hepatic, renal or heart disease 6)The pregnant patients or possibly pregnant patients 7)Patients unsuited for this study at a physician's discretion 8)Current treatment with gastric secretion inhibitors 9)Type 1 diabetes mellitus

发起方

Hachinohe City Hospital Department of Endocrinology and Diabetes